Hysterectomy: The most cost-effective solution for heavy menses

Article

Using available evidence on effectiveness, cost and utility values, hysterectomy is a more cost-effective solution for heavy menstrual bleeding than first- or second-generation endometrial ablation techniques or the levonorgestrel-releasing intrauterine system, according to a new UK analysis.

Using available evidence on effectiveness, cost, and utility values, hysterectomy is a more cost-effective solution for heavy menstrual bleeding than first- or second-generation endometrial ablation techniques or the levonorgestrel-releasing intrauterine system (Mirena; Bayer Healthcare, Morristown, New Jersey), according to the results of a recent analysis from the United Kingdom.

The researchers found that although hysterectomy is more expensive than the other 3 options tested, it produces more quality adjusted life years (QALYs) than the other strategies and is, therefore, more likely to be considered cost-effective. They calculated the incremental cost-effectiveness ratio for hysterectomy compared with Mirena to be $2,350 per additional QALY and the incremental cost-effectiveness ratio for hysterectomy compared with second-generation ablation to be $1,603. Second-generation ablation techniques and Mirena are less expensive, less invasive, and produce more QALYs than first-generation ablation techniques.

Although the results are consistent with those of other studies, the authors caution that they are highly sensitive to the utility values used. They also report that their results somewhat conflict with what is actually going on in clinical practice, which is that a reduction in the use of hysterectomy for heavy menstrual bleeding has occurred over the past decade, with women and their physicians favoring second-generation ablation techniques and Mirena.

Roberts TE, Tsourapas A, Middleton LJ, et al. Hysterectomy, endometrial ablation, and levonorgestrel releasing intrauterine system (Mirena) for treatment of heavy menstrual bleeding: cost effectiveness analysis. BMJ. 2011;342:d2202.

Related Videos
Understanding combined oral contraceptives and breast cancer risk | Image Credit: health.ucdavis.edu
Why doxycycline PEP lacks clinical data for STI prevention in women
The importance of nipocalimab’s FTD against FNAIT | Image Credit:  linkedin.com
Enhancing cervical cancer management with dual stain | Image Credit: linkedin.com
Fertility treatment challenges for Muslim women during fasting holidays | Image Credit: rmanetwork.com
Understanding the impact of STIs on young adults | Image Credit: providers.ucsd.edu.
CDC estimates of maternal mortality found overestimated | Image Credit: rwjms.rutgers.edu.
Study unveils maternal mortality tracking trends | Image Credit: obhg.com
How Harmonia Healthcare is revolutionizing hyperemesis gravidarum care | Image Credit: hyperemesis.org
Unveiling gender disparities in medicine | Image Credit:  findcare.ahn.org.
Related Content
© 2024 MJH Life Sciences

All rights reserved.